Quantcast

Latest Brain tumor Stories

2014-05-21 08:29:53

Multi-institutional radiotherapy planning study compared Leksell Gamma Knife Perfexion with three advanced linear-accelerator based stereotactic radiosurgery systems NEW YORK, May 21, 2014 /PRNewswire/ -- Persons who need radiotherapy for treatment of multiple brain metastases stand to receive as much as a 74 percent lower radiation dose to normal brain tissue if the lesions are treated with Elekta's Leksell Gamma Knife® Perfexion(TM) radiosurgery system versus contemporary...

2014-05-20 23:08:25

Barnes-Jewish Hospital was one of the first hospitals in the country to offer patients the opportunity to have brain surgery using technology that reduced the need for follow-up surgery. Now, its neurosurgery team has reached a milestone by performing more than 1,000 cases using its moveable intraoperative MRI system – more than any other center in the United States. St. Louis (PRWEB) May 20, 2014 Barnes-Jewish Hospital was one of the first hospitals in the country to offer patients the...

2014-05-20 20:22:05

VANCOUVER, British Columbia and MENLO PARK, Calif., May 20, 2014 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" and "DelMar Pharma") provided a quarterly update and a summary of progress toward the Company's goals for the year. DelMar also announced an investor conference call to take place on Thursday June 5, 2014 at 11:30 am EDT. Details and log-in information will be posted on the website at www.delmarpharma.com in advance of the call. Highlights from the...

2014-05-20 08:31:42

CALGARY, May 20, 2014 /PRNewswire/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC) (NASDAQ:ONCY) today announced that an abstract detailing early results from translational study looking at the intravenous administration of REOLYSIN(®) to patients with primary or metastatic brain tumors is now available on the ASCO Annual Meeting abstract website at http://abstracts.asco.org. The conference is being held from May 30(th) to June 3(rd), 2014 in Chicago, Illinois. "Treatment...

2014-05-19 08:28:02

A registry of 457 recurrent glioblastoma patients shows that patients treated commercially with NovoTTF Therapy in 2012 and 2013 achieved the longest median overall survival yet shown in non-experimental use for patients with recurrent glioblastoma NEW YORK, May 19, 2014 /PRNewswire/ -- Novocure, a commercial stage oncology company, announced today that an analysis of the efficacy and safety data from its U.S. patient registry will be published as part of the 50(th) meeting of the...

herpes virus attack a brain tumor cell
2014-05-18 03:00:47

Harvard Stem Cell Institute (HSCI) Harvard Stem Cell Institute (HSCI) scientists at Massachusetts General Hospital have a potential solution for how to more effectively kill tumor cells using cancer-killing viruses. The investigators report that trapping virus-loaded stem cells in a gel and applying them to tumors significantly improved survival in mice with glioblastoma multiforme, the most common brain tumor in human adults and also the most difficult to treat. The work, led by Khalid...

2014-05-16 12:20:36

UC Health News Just because you can’t see something doesn’t mean it’s not there. Brain tumors are an extremely serious example of this and are not only difficult to treat—both adult and pediatric patients have a five-year survival rate of only 30 percent—but also have even been difficult to image, which could provide important information for deciding next steps in the treatment process. However, Cincinnati Cancer Center research studies published in an April online issue...

2014-05-16 08:26:16

30mg/m2 dose cohort had been completed; enrollment of 40mg/m2 cohort has been initiated VANCOUVER, British Columbia and MENLO PARK, Calif., May 16, 2014 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") is pleased to provide an update on the company's ongoing Phase I/II clinical trial for VAL-083 in recurrent glioblastoma multiforme (GBM). DelMar has completed enrollment of VAL-083 dose Cohort 6 and advanced to Cohort 7. DelMar most recently presented...

2014-05-15 23:13:19

May is brain tumor awareness month. ANS in Morristown discusses Next-Generation Treatments, Community Awareness and their program Partnership of Hope. Morristown, NJ (PRWEB) May 15, 2014 Brain tumors are the second leading cause of cancer related deaths in children and young adults ages 15- 34. For over 50 years, Atlantic NeuroSurgical Specialists (ANS) has maintained their core value that the needs of their patients come first. This means constantly striving toward the application of...

2014-05-15 23:01:53

Advances in Neuroblastoma Research Association Recognizes Physician-Investigator's Progress Against a Challenging Childhood Cancer Philadelphia, Pa (PRWEB) May 15, 2014 The Advances in Neuroblastoma Research Association (ANRA) is conferring its highest honor on pediatric oncologist Garrett M. Brodeur, M.D., of the Cancer Center at The Children’s Hospital of Philadelphia (CHOP). Brodeur will receive the ANRA Lifetime Achievement Award tomorrow at the association’s international...


Word of the Day
siliqua
  • A Roman unit of weight, 1⁄1728 of a pound.
  • A weight of four grains used in weighing gold and precious stones; a carat.
  • In anatomy, a formation suggesting a husk or pod.
  • The lowest unit in the Roman coinage, the twenty-fourth part of a solidus.
  • A coin of base silver of the Gothic and Lombard kings of Italy.
'Siliqua' comes from a Latin word meaning 'a pod.'
Related